When approached strategically, RWD can help confirm long-term safety and performance, strengthen your clinical evidence base, support label expansions, and identify unmet clinical needs. The challenge lies in building a framework that is both methodologically robust and proportionate to your device and regulatory context..

Precision diagnostics is at the heart of cancer care, but increasing complexity means innovations can get lost in the noise. Clinicians, under time pressure, often struggle to distinguish between tests and rely on familiarity, habit, and brand trust when making decisions.